Details for 2017191721

Up to date per 02.04.2026

Actions

Title / Product Name

RSV-F-PRÄFUSIONSANTIGENE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017191721

EP Publication Number

3275892

E-Number

1222594

Language

PCT Number

Publication Date

31.01.2018 A

08.01.2020 B1

Registration Date

08.01.2020

AT Publication Date

15.02.2020

Application Date

14.05.2012

Registration Number

Priorities

13.05.2011

201161486005 P

IPC

C07K 14/135 20060101AFI20180206BHEP

Maximum Duration of Protection

14.05.2032

Owner

GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE

Representative

Sonn & Partner PatentanwälteRiemergasse 141010 WienAT

Inventor

SWANSON, Kurtc/o Novartis Vaccines And Diagnostics, Inc. P.O. Box 8097 Emeryville, CA 94662-8097US

CARFI, Andreac/o Novatis Vaccines And Diagnostics, Inc. P.O. Box 8097 Emeryville, CA 94662-8097US